Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00158977 | CONTAK RENEWAL 3 AVT | PHASE3 | COMPLETED | 73 | — | — | Nov 1, 2003 | Feb 1, 2008 | Sep 29, 2011 | 1 | United States |
| Name | Type | Description |
|---|---|---|
| CONTAK RENEWAL 3 AVT | DEVICE | CONTAK RENEWAL 3 AVT |
Inclusion Criteria: Patients who meet the following criteria should be given consideration for inclusion in the clinical investigation: * Meet all device indications and contraindications * Willing and capable of providing informed consent, undergoing a device implant, participating in all testing...